Fidelity Disruptive Medicine ETF
FMEDETF · Nasdaq
$33.52
+$0.28 (+0.84%)
EOD Oct 29, 2026
Key facts
- Expense ratio
- 0.5%
- Dividend yield (TTM)
- 0.00%
- Distributions
- Semi-annual
- Fund net assets (Aug 2026)
- $52M
- Stocks held
- 72
- Other positions
- 2
- Turnover (last fiscal year)
- 49%
- 52-week range
- $23.48 to $33.52
Top 10 holdings
All holdings33.2% of assets in ten stocks, as of Aug 31, 2026
| Company | Weight | Quality |
|---|---|---|
| 5.19% | 48 | |
| 3.83% | 31 | |
| 3.73% | 23 | |
| 3.30% | 61 | |
| 3.20% | 67 | |
| 3.00% | 59 | |
| 2.87% | 10 | |
| 2.82% | 68 | |
| 2.72% | 20 | |
| 2.59% | 49 |
Sector allocation
Share of the fund's assets
- Healthcare80.1%
- Industrials16.2%
- Technology0.9%
Scores of what it owns
Every holding's scoreEach holding's score, weighted by its size in the fund
8% of the fund's stock weight sits in companies with a Quality score above 75, 57% in companies below 50.
Where it invests
Stock weight by the company's home country
- United States81.1%
- Netherlands4.4%
- Cayman Islands2.6%
- France2.6%
- Bermuda2.2%
- Denmark2.0%
- United Kingdom1.8%
- Belgium1.6%
And 1 more countries.
Growth of $10,000
With and without the dividends reinvested
Dividend
Dividend historyFMED has not paid a dividend in the last twelve months; the last payment was ex-dividend Dec 20, 2024.
Average annual returns
Total return at net asset value, to May 31, 2026, as reported to the SEC
| 1 year | 5 years | 10 years |
|---|---|---|
| 8.04% | 2.35% | 2.49% |
Past returns say nothing certain about future ones.
FMED questions
What does FMED invest in?+
Fidelity Disruptive Medicine ETF is an exchange-traded fund. Its largest holdings are 10x Genomics Inc. (5.19%), Thermo Fisher Scientific Inc. (3.83%), Danaher Corporation (3.73%).
What is FMED's expense ratio?+
0.5% a year, as stated in the fund's latest shareholder report filed with the SEC. On a $10,000 investment that is about $50.00 a year.
How good are the companies FMED owns?+
Weighted by position size, the stocks in FMED average a Quality score of 43 out of 100. 8% of the fund's stock weight sits in companies scoring above 75, 57% in companies below 50. The score is computed from each company's SEC filings; the methodology page lists every check.
Holdings: the fund's latest SEC Form N-PORT, as of Aug 31, 2026. Expense ratio, turnover and returns: the fund's shareholder report (SEC Form N-CSR) for the period to May 31, 2026. Net assets: SEC Form N-PORT. Quality scores: computed by Intrinsiqq from each company's SEC filings (methodology). Price: end of day Oct 29, 2026.